4
Changes in Ownership
NEUROCRINE BIOSCIENCES INC Filed Acc 0001209191-19-048482
Chief Legal Officer sold 6,736 shares at $100.00 ($673,600)
- Chief Legal Officer acquired 6,736 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Lippoldt Darin · Chief Legal Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-09-03 | Exercise or conversion : show line 1 in the form | +6,736 | $32.99 | $222,221 | 26,839 | D |
| 2019-09-03 | Sale : show line 2 in the form | −6,736 | $100.00 | $673,600 | 20,103 | D |
| Open-market sales · 6,736 sh · avg $100.00 · $673,600 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|
| 2019-09-03 | Exercise or conversion : show line 3 in the form Non-Qualified Stock Option | −6,736 | $32.99 | $222,221 | $32.99 | 2025-02-03 | 6,736 | 6,625 | D |
Loading xslF345X03/doc4.xml…